Meetings:

Federal Register Volume 76, Number 106 (Thursday, June 2, 2011)

Notices

Pages 31967-31968

From the Federal Register Online via the Government Printing Office [www.gpo.gov]

FR Doc No: 2011-13665

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute On Drug Abuse; Notice of Closed Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5

U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Drug Abuse Special

Emphasis Panel; NIDA R13 Conference Grant Review.

Date: June 10, 2011.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001

Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).

Contact Person: Minna Liang, PhD, Scientific Review Officer,

Grants Review Branch, Office of Extramural Affairs, National

Institute on Drug Abuse, NIH, Room 4226, MSC 9550, 6001 Executive

Blvd., Bethesda, MD 20892-9550, 301-435-1432, liangm@nida.nih.gov.

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

Name of Committee: National Institute on Drug Abuse Special

Emphasis Panel; Medical Marijuana Policy Research.

Date: June 15, 2011.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military

Road, NW., Washington, DC 20015.

Contact Person: Gerald L. McLaughlin, PhD, Scientific Review

Officer, Office of Extramural Affairs, National Institute on Drug

Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd.,

Bethesda, MD 20892-9550, 301-402-6626, gm145a@nih.gov.

Name of Committee: National Institute on Drug Abuse Special

Emphasis Panel; Predictive Animal Models for Smoking Cessation

Medications (U54).

Date: June 16, 2011.

Time: 1 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001

Executive Boulevard, Rockville, MD 20852 (Telephone Conference

Call).

Contact Person: Scott A. Chen, PhD, Scientific Review

Administrator, Office of Extramural Affairs, National Institute on

Drug Abuse, NIH, DHHS, Room 4234, MSC 9550, 6001 Executive Blvd.,

Bethesda, MD 20892-9550, 301-443-9511, chensc@mail.nih.gov.

Name of Committee: National Institute on Drug Abuse Special

Emphasis Panel; Blueprint for Neuroscience Research Science

Education Award R25).

Date: June 28, 2011.

Time: 8 a.m. to 5:30 p.m.

Agenda: To review and evaluate grant applications.

Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military

Road, NW., Washington, DC 20015.

Contact Person: Gerald L. McLaughlin, PhD, Scientific Review

Officer, Office of Extramural Affairs, National Institute on Drug

Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd.,

Bethesda, MD 20892-9550, 301-402-6626, gm145a@nih.gov.

Name of Committee: National Institute on Drug Abuse Special

Emphasis Panel; NIDA-K Conflicts.

Date: June 29, 2011.

Time: 5 p.m. to 8 p.m.

Agenda: To review and evaluate grant applications.

Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes

Street, Arlington, VA 22202.

Contact Person: Gerald L. McLaughlin, PhD, Scientific Review

Officer, Office of Extramural Affairs, National Institute on Drug

Abuse, NIH, DHHS, Room 4238, MSC

Page 31968

9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 301-402-6626, gm145a@nih.gov.

Name of Committee: National Institute on Drug Abuse Special

Emphasis Panel; Exploring iPS Cells in Substance Abuse Research

(R21).

Date: June 30, 2011.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Minna Liang, PhD, Scientific Review Officer,

Grants Review Branch, Office of Extramural Affairs, National

Institute on Drug Abuse, NIH, Room 4226, MSC 9550, 6001 Executive

Blvd., Bethesda, MD 20892-9550, 301-435-1432, liangm@nida.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug

Abuse and Addiction Research Programs, National Institutes of

Health, HHS)

Dated: May 26, 2011.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

FR Doc. 2011-13665 Filed 6-1-11; 8:45 am

BILLING CODE 4140-01-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT